Education
About Us
Working with TipRanks
Follow Us
Lobe Sciences (LOBEF)
OTHER OTC:LOBEF
LOBEF Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.06
Previous CloseN/A
Volume171.00
Average Volume (3M)202.47K
Market Cap
$6.31M
Enterprise Value$7.48M
Total Cash (Recent Filing)$24.29K
Total Debt (Recent Filing)$2.15M
Price to Earnings (P/E)―
Beta-0.35
Next Earnings
Dec 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding193,198,330
10 Day Avg. Volume190,119
30 Day Avg. Volume202,475
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.18
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-264.76
Enterprise Value/Ebitda-1.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Lobe Sciences News
LOBEF FAQ
What was Lobe Sciences’s price range in the past 12 months?
Lobe Sciences lowest stock price was <$0.01 and its highest was $0.06 in the past 12 months.
What is Lobe Sciences’s market cap?
Lobe Sciences’s market cap is $6.31M.
When is Lobe Sciences’s upcoming earnings report date?
Lobe Sciences’s upcoming earnings report date is Dec 19, 2025 which is in 129 days.
How were Lobe Sciences’s earnings last quarter?
Lobe Sciences released its earnings results on Jul 30, 2025. The company reported -$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.004.
Is Lobe Sciences overvalued?
According to Wall Street analysts Lobe Sciences’s price is currently Overvalued.
Does Lobe Sciences pay dividends?
Lobe Sciences does not currently pay dividends.
What is Lobe Sciences’s EPS estimate?
Lobe Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lobe Sciences have?
Lobe Sciences has 193,198,330 shares outstanding.
What happened to Lobe Sciences’s price movement after its last earnings report?
Lobe Sciences reported an EPS of -$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Lobe Sciences?
Currently, no hedge funds are holding shares in LOBEF
Company Description
Lobe Sciences
Lobe Sciences Ltd., a life sciences company, focuses on the research and development of psychedelic medicines. It develops psilocybin-based therapeutics in combination with N-acetylcysteine for the treatment of mild traumatic brain injuries and post-traumatic stress disorder, as well as devices for the efficient application of medications. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.
Technical Analysis
Ayurcann Holdings Corp.
―
Willow Biosciences Inc
―
1933 Industries
―
Blueberries Medical
―
4Front Ventures
―
Ownership Overview
Options Prices
Currently, No data available
---